Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation

被引：43
作者：
Monteiro, I
McLoughlin, LM
Fisher, A
De la Torre, AN
Koneru, B
机构：
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Newark, NJ 07103 USA
来源：
TRANSPLANTATION | 2003年 / 76卷 / 11期
关键词：
D O I：
10.1097/01.TP.0000082723.02477.87
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1648 / 1649
页数：2
相关论文
共 5 条
  • [1] THE USE OF ABO-INCOMPATIBLE GRAFTS IN LIVER-TRANSPLANTATION - A LIFESAVING PROCEDURE IN HIGHLY SELECTED PATIENTS
    FARGES, O
    KALIL, AN
    SAMUEL, D
    SALIBA, F
    ARULNADEN, JL
    DEBAT, P
    BISMUTH, A
    CASTAING, D
    BISMUTH, H
    [J]. TRANSPLANTATION, 1995, 59 (08) : 1124 - 1133
  • [2] FISCHEL RJ, 1989, TRANSPLANT P, V21, P2221
  • [3] Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab
    Sharma, VR
    Fleming, DR
    Slone, SP
    [J]. BLOOD, 2000, 96 (03) : 1184 - 1186
  • [4] Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.
    Suzan, F
    Ammor, M
    Ribrag, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) : 1000 - 1000
  • [5] TOMA H, 1994, UROL CLIN N AM, V21, P299
1